About US
Contact us
-
USFDA approves Sun Pharma's generic Venlafaxine Hydrochloride Extended Release tablets ANDASun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets. These generi2010/8/20
-
Commissioner Shao Mingli meets Commissioner of the U.S. Food and Drug AdministrationOn August 11, 2010, Shao Mingli, Commissioner of the State Food and Drug Administration, met with the visiting Dr. Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration, and her ento2010/8/20
-
Jiangbo receives Shandong FDA approval to market Felodipine SR tabletsJiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced that the Company received approval from the Shandong Food and Drug Administration ("Shandong FDA") to start t2010/8/17
-
SFDA issues guides for routine on-site inspection to health food and cosmetics production and distribution enterprisesThe State Food and Drug Administration (SFDA) recently issued guides for routine on-site inspection to health food and cosmetics production and distribution enterprises, defining the basic procedure2010/8/17
-
SFDA exposes 14 illegal drug websitesThe State Food and Drug Administration (SFDA) recently issued 2010 Second Safety Warning Announcement Regarding Buying Medicines Online and exposed 14 websites releasing false drug information and s2010/8/17
-
Eli Lilly to appeal against U.S. District Court ruling in Strattera patent litigationEli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera® (atomoxetine). I2010/8/16
-
Lamictal can cause aseptic meningitis: FDAThe U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protec2010/8/16
-
Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPsBristol-Myers Squibb Company (NYSE: BMY) and the ADAP Crisis Task Force (ACTF) today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs (ADAPs) to provide antiretr2010/8/13
-
Simcere subsidiary receives Chinese SFDA approval to manufacture and market PalonosetronSimcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary2010/8/13
-
Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize EplerenoneSinobiopharma, Inc. (OTCBB:SNBP) ("Sinobiopharma" or the "Company"), an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wh2010/8/12